(HealthDay News) — Among opioid-naive men, 5 or fewer tablets of opioid medication with a nonopioid care pathway provides satisfactory pain control following outpatient urethral surgery, according to a study published in the March issue of Urology Practice.
Bridget L. Findlay, MD, from the Mayo Clinic in Rochester, Minnesota, and colleagues prospectively followed 116 men undergoing outpatient anterior urethroplasty by a single surgeon from August 2017 to January 2021.
The researchers found that one-third of patients did not use opioids postoperatively, and nearly 78% of patients used 5 or fewer tablets. A median of 2 opioid tablets were used and a median of 8 tablets were unused. Preoperative opioid use was the only predictor for use of more than 5 tablets (75% vs 25% percent). Patients who used tramadol postoperatively reported higher satisfaction and greater percentages of pain reduction (80% vs 50%) versus those using oxycodone.
Continue Reading
“A multimodal, limited opioid pain management pathway using a small quantity of adjunctive opioid provides adequate pain control after outpatient urethroplasty,” the authors write. “The ultimate goal is to optimize multimodal pain pathways and perioperative patient counseling in order to transition to a fully narcotic-free pathway. With the rise in electronic prescribing and close follow-up through patient-provider electronic communications, future studies should be directed toward the impact of these resources on opioid-free pathways.”
